Figure 4
From: Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy
BSI progression in a metastatic hormone-resistant prostate cancer patient.This figure shows posterior views of baseline (A) and follow-up (B)whole-body bone scans of a metastatic hormone-resistant prostate cancer patient.Hot spots, presented in red, represent the bone area affected by tumour. The BSIchange from baseline to follow-up shows BSI progression in accordance with patient's high BSI change after androgen deprivation therapy.According to our results, high BSI changes are significantly associated with poorer prognosis.